Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01319 |
| Species: | Homo sapiens |
| Position : | chr5:1320000-1322000 |
| Year: | 2024 |
| Title: | Focal deletions of a promoter tether activate the IRX3 oncogene in T-cell acute lymphoblastic leukemia |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| Disease Name: | -- |
| PMID: | 39316719 |
| MONDO: | |
| Tissue: | Embryonic Kidney |
| Tissue Ontology ID: | UBERON:0002113 |
| Cell Source: | HEK293 |
| CVCL ID: | CVCL_0045 |
| Cell Type: | embryonic kidney cell |
| Cell Ontology ID: | CL:0002139 |
| Experiment Type: | Enhancer activity assay, Functional perturbation assay, TF binding assay, Chromatin interaction assay |
| High Throughput Method: | ChIP-seq, Hi-C, ChIA-PET, RNA-seq, WGS |
| Low Throughput Method: | CRISPR Knockout, RT-RT-qPCR, 4C-seq, ChIP-RT-qPCR, Sanger Sequencing |
| Target gene : | TERT |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|